American Pharmacists Association applauds FTC action on PBMs' alleged inflation of insulin drug prices

WASHINGTON, Sept. 20, 2024 /PRNewswire/ -- Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically integrated pharmacy benefit managers (PBMs) "for...